Concepedia

Author

Mario Del Tacca

University of Pisa

Also Known As

Del Tacca, M., M D Tacca, M Del Tacca, M Tacca, M del Tacca, M. DEL TACCA, M. Del Tacca, M. Tacca, M. del Tacca, M.Del Tacca

502

Publications

9.8K

Citations

56

H-Index

173

Concepts

All Affiliations

University of PisaScuola Superiore Sant'AnnaAzienda Ospedaliera Universitaria PisanaOspedale Santa Chiara
MD

About

Mario Del Tacca is an author at University of Pisa specializing in medicine, pharmacology, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

37

105

3.8K

2

Health Sciences

10

10

327

3

Natural Sciences

3

3

121

4

Public Health

2

2

68

5

Education

1

1

22

Mario Del Tacca

×

175

Publications

7.4K

Citations

50

H-Index

YearCitations

Transcription Analysis of Human Equilibrative Nucleoside Transporter-1 Predicts Survival in Pancreas Cancer Patients Treated with Gemcitabine

Elisa Giovannetti, Mario Del Tacca, Valentina Mey,

Cancer Research

2006

346

Correlation of <i>CDA, ERCC1</i>, and <i>XPD</i> Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile,

Clinical Cancer Research

2008

207

Prostaglandins from tumours of human large bowel

A. B. Bennett, Mario Del Tacca, I F Stamford,

British Journal of Cancer

1977

201

Cellular and Pharmacogenetics Foundation of Synergistic Interaction of Pemetrexed and Gemcitabine in Human Non–Small-Cell Lung Cancer Cells

Elisa Giovannetti, Valentina Mey, Sara Nannizzi,

Molecular Pharmacology

2005

177

Biweekly Chemotherapy With Oxaliplatin, Irinotecan, Infusional Fluorouracil, and Leucovorin: A Pilot Study in Patients With Metastatic Colorectal Cancer

Alfredo Falcone, Gianluca Masi, Giacomo Allegrini,

Journal of Clinical Oncology

2002

156

Cardiotoxicity of Epirubicin/Paclitaxel–Containing Regimens: Role of Cardiac Risk Factors

Alessandra Gennari, B. Salvadori, Sara Donati,

Journal of Clinical Oncology

1999

114

Cyclophosphamide-methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation

Guido Bocci, Marco Tuccori, Urban Emmenegger,

Annals of Oncology

2005

107

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients

Antonello Di Paolo, Romano Danesi, Alfredo Falcone,

Annals of Oncology

2001

107

Synergistic Cytotoxicity and Pharmacogenetics of Gemcitabine and Pemetrexed Combination in Pancreatic Cancer Cell Lines

Elisa Giovannetti, Valentina Mey, Romano Danesi,

Clinical Cancer Research

2004

103

Cyclooxygenase-2 Inhibition Improves Vascular Endothelial Dysfunction in a Rat Model of Endotoxic Shock: Role of Inducible Nitric-Oxide Synthase and Oxidative Stress

Agostino Virdis, Rocchina Colucci, Matteo Fornai,

Journal of Pharmacology and Experimental Therapeutics

2005

101

Page 1